Belite Bio (BLTE) Other Non Operating Income (2024 - 2026)

Belite Bio's (BLTE) quarterly Other Non Operating Income came in at -$13.2 million in Q1 2026, down 97.84% year-on-year from -$611.2 million in Q1 2025, and down 12.64% quarter-over-quarter from -$11.7 million in Q4 2025.

Belite Bio (BLTE) Other Non Operating Income (2024 - 2026) Analysis & Trends

Belite Bio's Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$13.2 million for Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 97.84% year-over-year to -$13.2 million in Q1 2026; TTM through Mar 2026 was -$35.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$41000.0, down 129.08% from the prior year.
  • Other Non Operating Income declined to -$13.2 million in Q1 2026 per BLTE's latest filing, from -$11.7 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at -$4.2 million in Q4 2024 and bottomed at -$13.2 million in Q1 2026.
  • The 3-year median for Other Non Operating Income is -$9.2 million (2025), against an average of -$8.9 million.
  • Across the five-year window, Other Non Operating Income plunged 178.53% in 2025 and sank 97.84% in 2026, its largest moves.
  • Year by year, Other Non Operating Income stood at -$4.2 million in 2024, then plunged by 178.53% to -$11.7 million in 2025, then retreated by 12.64% to -$13.2 million in 2026.
  • Per Business Quant, the three latest BLTE Other Non Operating Income figures stand at -$13.2 million (Q1 2026), -$11.7 million (Q4 2025), and -$6.7 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.20 Mn
Dec 31, 2025 -11.72 Mn
Mar 31, 2025 -6.67 Mn
Dec 31, 2024 -4.21 Mn